Asunercept in Patients With Severe COVID-19
Clinical trial NCT04535674 · COMPLETED
Trial details
- NCT number
- NCT04535674
- Sponsor
- Apogenix AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2021-10-29
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.